DUSTIN LATIMER: Open Payments
NPI 1760715213 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 32 payments from 5 companies in 2025. Trend: 2023 $1,141 · 2024 $782 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 13 | $364 |
| ViiV Healthcare Company | 9 | $193 |
| Merck Sharp & Dohme LLC | 8 | $152 |
| Lilly USA, LLC | 1 | $115 |
| ABBVIE INC. | 1 | $26 |
Products named: PIFELTRO, APRETUDE, Yeztugo, ZEPBOUND, DOVATO, MAVYRET, Biktarvy, CABENUVA.
Industry payments across PA — which companies pay providers there.
